Lacdayeng, Jack Cyves .

HRN: 29-01-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/15/2026
06/21/2026
IV
450mg
Q8hours
PCAP-C; T/c HAP
Checking Initial Appropriateness 
06/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/20/2026
06/27/2026
IV
28mg
Q8
PCAP
Checking Initial Appropriateness 
06/23/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/23/2026
06/29/2026
ORAL
1.5ml
OD
PCAP D
Rejected 
06/23/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/23/2026
06/30/2026
PO
1ml
Q6
Oral Sores
Checking Initial Appropriateness 
06/23/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/23/2026
06/29/2026
IV
60mg
Q12
HAP
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: